ABSTRACT
Ochrobactrum anthropi infection in newborn patients is rare, and the treatment is challenging because of its widespread and unpredictable resistance to antimicrobial agents and discrepancies between in vitro susceptibility and in vivo efficacy. We report the clinical and microbiological characteristics of Ochrobactrum anthropi bacteremia in a preterm patient.
Subject(s)
Adult , Female , Humans , Infant, Newborn , Bacteremia/diagnosis , Bacteremia/pathology , Cystic Fibrosis/complications , Ochrobactrum anthropi/isolation & purification , Anti-Bacterial Agents/pharmacology , Bacteremia/microbiology , Infant, Premature , Microbial Sensitivity Tests , Ochrobactrum anthropi/classification , Ochrobactrum anthropi/drug effects , Ochrobactrum anthropi/geneticsABSTRACT
We report a case of spontaneous bacterial peritonitis from Ochrobactrum anthropi. O. anthropi is recognized as an emerging pathogen in immunocompromised patients. In contrast to most previously described cases, the patient reported here had no indwelling catheter. To our knowledge, no case of O. anthropi spontaneous bacterial peritonitis has been reported in the medical literature until now.